Korean biotech firm Orum Therapeutics lands $8 mln Series A

Korean biotech company Orum Therapeutics has closed $8 million in Series A financing. The investors were InterVest, KB Investment/Solidus Investment and LB Investment. In addition to the funding, Dr. Yeo Jung Moon of Intervest will join Orum’s board of directors.

Source: Press Release